{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T08:00:34Z","timestamp":1780214434959,"version":"3.54.0"},"posted":{"date-parts":[[2026,5,31]]},"group-title":"In Review","reference-count":115,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,5,13]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Background: Prostate cancer (PCa) is the most common cancer in US men, with Black men experiencing the highest incidence rates and Black and Hispanic men experiencing higher aggressive PCa rates than White men. Metabolomic dysregulation is a cancer hallmark; however, PCa metabolomic epidemiological evidence is heterogeneous and limited in diverse populations. \nMethods: We conducted a metabolome-wide two-sample Mendelian randomization (MR) of PCa risk in African (AFR) and European (EUR) genetic ancestry and Hispanic (HIS) ethnicity populations. MR was performed in each population using serum metabolomic genome-wide association study (GWAS) summary statistics from ARIC (N\n                  <sub>Metabolites<\/sub>\n                  =250, N\n                  <sub>AFR<\/sub>\n                  =1,740, N\n                  <sub>EUR<\/sub>\n                  =1,498) and HCHS\/SOL (N\n                  <sub>Metabolites<\/sub>\n                  =711, N\n                  <sub>HIS<\/sub>\n                  =3,166) and PCa GWAS summary statistics from PRACTICAL (N\n                  <sub>AFR<\/sub>\n                  =19,391\/61,608, N\n                  <sub>EUR<\/sub>\n                  =122,188\/604,640, N\n                  <sub>HIS<\/sub>\n                  =3,931\/26,405 cases\/controls). MR results were meta-analyzed across populations. \nResults: We identified 61 significant associations representing 50 unique metabolites in population-specific or cross-population analyses, with enrichment for lipids, including polyunsaturated fatty acids. Upon evaluating the strength of evidence, considering sensitivity analyses and the consistency of findings across populations, fourteen metabolites had strong evidence, including three drug-modifiable and six dietary-modifiable metabolites. Five were novel metabolites not previously reported in PCa MR studies, including two identified in AFR-specific associations: lysophospholipid 1-linoleoyl-GPE (18:20) and fatty acid hexadecanedioate, with colocalization suggesting a shared causal variant (rs28864441) between hexadecanedioate and PCa, and three identified in cross-population associations: amino acid 3-methoxytryosine, fatty acid 2-hydroxysterate, and peptide gamma-glutamylleucine. \nConclusions: Our findings provide evidence of associations between serum metabolites, particularly fatty acids, and PCa development across populations. The biological mechanisms and clinical utility of these metabolites as biomarkers of PCa risk warrant further investigation.\n                <\/p>","DOI":"10.21203\/rs.3.rs-9708129\/v1","type":"posted-content","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T07:09:42Z","timestamp":1780211382000},"source":"Crossref","is-referenced-by-count":0,"title":["Cross-population metabolome-wide Mendelian randomization study of prostate cancer risk"],"prefix":"10.21203","author":[{"given":"Harriett","family":"Fuller","sequence":"first","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Rohde","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M","family":"Highland","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Haessler","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Wu","sequence":"additional","affiliation":[{"name":"Louisiana State University Health Sciences Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariaelisa","family":"Graff","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A","family":"Platz","sequence":"additional","affiliation":[{"name":"John Hopkins"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn","family":"Alkis","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yu","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boerwinkle","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Grove","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Kooperberg","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Peters","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari E","family":"North","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V","family":"Conti","sequence":"additional","affiliation":[{"name":"CU Anschutz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A","family":"Haiman","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L","family":"Young","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E","family":"Graff","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu F","family":"Darst","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"1","key":"ref1","first-page":"e70043","article-title":"Cancer statistics, 2026. CA: A Cancer","volume":"76","author":"Siegel RL","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, et al. Cancer statistics, 2026. CA: A Cancer. J Clin. 2026;76(1):e70043.","journal-title":"J Clin"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41588-020-00748-0","article-title":"Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction","volume":"53","author":"Conti DV","year":"2021","unstructured":"Conti DV, Darst BF, Moss LC, et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat Genet. 2021;53(1):65\u201375.","journal-title":"Nat Genet"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial Risk and Heritability of Cancer Among Twins in Nordic Countries","volume":"315","author":"Mucci LA","year":"2016","unstructured":"Mucci LA, Hjelmborg JB, Harris JR, et al. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. JAMA. 2016;315(1):68\u201376.","journal-title":"JAMA"},{"issue":"2","key":"ref4","first-page":"111","article-title":"Cancer statistics for African American and Black people, 2025","volume":"75","author":"Saka AH","year":"2025","unstructured":"Saka AH, Giaquinto AN, McCullough LE, et al. Cancer statistics for African American and Black people, 2025. CA Cancer J Clin. 2025;75(2):111\u201340.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41391-021-00451-z","article-title":"Racial disparities in prostate cancer among black men: epidemiology and outcomes","volume":"25","author":"Chowdhury-Paulino IM","year":"2022","unstructured":"Chowdhury-Paulino IM, Ericsson C, Vince R Jr., et al. Racial disparities in prostate cancer among black men: epidemiology and outcomes. Prostate Cancer Prostatic Dis. 2022;25(3):397\u2013402.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1292577","DOI":"10.3389\/fonc.2023.1292577","article-title":"Incidence trends in prostate cancer among men in the United States from 2000 to 2020 by race and ethnicity, age and tumor stage","volume":"13","author":"Du XL","year":"2023","unstructured":"Du XL, Gao D, Li Z. Incidence trends in prostate cancer among men in the United States from 2000 to 2020 by race and ethnicity, age and tumor stage. Front Oncol. 2023;13:1292577.","journal-title":"Front Oncol"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/j.clgc.2023.10.002","article-title":"Prostate Cancer Disparities in Metastatic and Treatment Status for Hispanic Americans Based on Country of Origin Compared to Non-Hispanic Whites Using the National Cancer Database","volume":"22","author":"Estrada-Mendizabal RJ","year":"2024","unstructured":"Estrada-Mendizabal RJ, Dhaliwal AS, Bertolo AJ, et al. Prostate Cancer Disparities in Metastatic and Treatment Status for Hispanic Americans Based on Country of Origin Compared to Non-Hispanic Whites Using the National Cancer Database. Clin Genitourin Cancer. 2024;22(1):e148. -e55.e1.","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"ref8","first-page":"509","article-title":"Prostate-specific antigen testing rates in high-risk populations: results from the All of Us Research Program","volume":"35","author":"Morley F","year":"2024","unstructured":"Morley F, Iyer HS, Tamimi RM, et al. Prostate-specific antigen testing rates in high-risk populations: results from the All of Us Research Program. Cancer Causes Control. 2024;35(3):509\u201321.","journal-title":"Cancer Causes Control"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2022.01.028","article-title":"Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics","volume":"531","author":"Lowder D","year":"2022","unstructured":"Lowder D, Rizwan K, McColl C, et al. Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics. Cancer Lett. 2022;531:71\u201382.","journal-title":"Cancer Lett"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semradonc.2016.08.002","article-title":"Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography","volume":"27","author":"Rebbeck TR","year":"2017","unstructured":"Rebbeck TR. Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography. Semin Radiat Oncol. 2017;27(1):3\u201310.","journal-title":"Semin Radiat Oncol"},{"issue":"23","key":"ref11","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1200\/JCO.2016.66.7527","article-title":"Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer","volume":"34","author":"Preston MA","year":"2016","unstructured":"Preston MA, Batista JL, Wilson KM, et al. Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. J Clin Oncol. 2016;34(23):2705\u201311.","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/cncr.25568","article-title":"Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50","volume":"117","author":"Lilja H","year":"2011","unstructured":"Lilja H, Cronin AM, Dahlin A, et al. Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50. Cancer. 2011;117(6):1210\u20139.","journal-title":"Cancer"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2018.08.032","article-title":"Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men","volume":"75","author":"Preston MA","year":"2019","unstructured":"Preston MA, Gerke T, Carlsson SV, et al. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men. Eur Urol. 2019;75(3):399\u2013407.","journal-title":"Eur Urol"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/1055-9965.EPI-22-0443","article-title":"Association of Prostate-Specific Antigen Levels with Prostate Cancer Risk in a Multiethnic Population: Stability Over Time and Comparison with Polygenic Risk Score","volume":"31","author":"Chou A","year":"2022","unstructured":"Chou A, Darst BF, Wilkens LR, et al. Association of Prostate-Specific Antigen Levels with Prostate Cancer Risk in a Multiethnic Population: Stability Over Time and Comparison with Polygenic Risk Score. Cancer Epidemiol Biomarkers Prev. 2022;31(12):2199\u2013207.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s42255-023-00903-x","article-title":"Metabolomic epidemiology offers insights into disease aetiology","volume":"5","author":"Fuller H","year":"2023","unstructured":"Fuller H, Zhu Y, Nicholas J, et al. Metabolomic epidemiology offers insights into disease aetiology. Nat Metab. 2023;5(10):1656\u201372.","journal-title":"Nat Metab"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11306-021-01789-0","article-title":"A strategy for advancing for population-based scientific discovery using the metabolome: the establishment of the Metabolomics Society Metabolomic Epidemiology Task Group","volume":"17","author":"Lasky-Su J","year":"2021","unstructured":"Lasky-Su J, Kelly RS, Wheelock CE, et al. A strategy for advancing for population-based scientific discovery using the metabolome: the establishment of the Metabolomics Society Metabolomic Epidemiology Task Group. Metabolomics. 2021;17(5):45.","journal-title":"Metabolomics"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00204-010-0609-6","article-title":"The role of metabolites and metabolomics in clinically applicable biomarkers of disease","volume":"85","author":"Mamas M","year":"2011","unstructured":"Mamas M, Dunn WB, Neyses L, et al. The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol. 2011;85(1):5\u201317.","journal-title":"Arch Toxicol"},{"key":"ref18","article-title":"Hallmarks of cancer-Then and now, and beyond","author":"Hanahan D","year":"2026","unstructured":"Hanahan D. Hallmarks of cancer-Then and now, and beyond. Cell. 2026.","journal-title":"Cell"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-025-03312-x","article-title":"Pre-diagnostic circulating untargeted metabolomics and risk of overall and clinically significant prostate cancer: a systematic review and meta-analysis","author":"Fuller H","year":"2026","unstructured":"Fuller H, Agasaro OP, Guevara JM et al. Pre-diagnostic circulating untargeted metabolomics and risk of overall and clinically significant prostate cancer: a systematic review and meta-analysis. Br J Cancer. 2026.","journal-title":"Br J Cancer"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1158\/1055-9965.EPI-15-1223","article-title":"Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence","volume":"25","author":"Kelly RS","year":"2016","unstructured":"Kelly RS, Vander Heiden MG, Giovannucci E, et al. Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence. Cancer Epidemiol Biomarkers Prev. 2016;25(6):887\u2013906.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"102196","DOI":"10.1016\/j.tranon.2024.102196","article-title":"Prostate cancer risk biomarkers from large cohort and prospective metabolomics studies: A systematic review","volume":"51","author":"L\u00f3pez-Hern\u00e1ndez Y","year":"2025","unstructured":"L\u00f3pez-Hern\u00e1ndez Y, Andres-Lacueva C, Wishart DS, et al. Prostate cancer risk biomarkers from large cohort and prospective metabolomics studies: A systematic review. Transl Oncol. 2025;51:102196.","journal-title":"Transl Oncol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.18632\/aging.101837","article-title":"Longitudinal plasma metabolomics of aging and sex","volume":"11","author":"Darst BF","year":"2019","unstructured":"Darst BF, Koscik RL, Hogan KJ, et al. Longitudinal plasma metabolomics of aging and sex. Aging. 2019;11(4):1262\u201382.","journal-title":"Aging"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1158\/1055-9965.EPI-18-0079","article-title":"Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study","volume":"28","author":"Adams CD","year":"2019","unstructured":"Adams CD, Richmond R, Ferreira DLS, et al. Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study. Cancer Epidemiol Biomarkers Prev. 2019;28(1):208\u201316.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12864-022-08442-7","article-title":"Effects of glutamate and aspartate on prostate cancer and breast cancer: a Mendelian randomization study","volume":"23","author":"Lin Y","year":"2022","unstructured":"Lin Y, Yang Z, Li J, et al. Effects of glutamate and aspartate on prostate cancer and breast cancer: a Mendelian randomization study. BMC Genomics. 2022;23(1):213.","journal-title":"BMC Genomics"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/bjc.2016.228","article-title":"Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium","volume":"115","author":"Khankari NK","year":"2016","unstructured":"Khankari NK, Murff HJ, Zeng C, et al. Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium. Br J Cancer. 2016;115(5):624\u201331.","journal-title":"Br J Cancer"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/cam4.695","article-title":"Blood lipids and prostate cancer: a Mendelian randomization analysis","volume":"5","author":"Bull CJ","year":"2016","unstructured":"Bull CJ, Bonilla C, Holly JMP, et al. Blood lipids and prostate cancer: a Mendelian randomization analysis. Cancer Med. 2016;5(6):1125\u201336.","journal-title":"Cancer Med"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12916-024-03272-8","article-title":"Plasma metabolites and risk of seven cancers: a two-sample Mendelian randomization study among European descendants","volume":"22","author":"Chen Y","year":"2024","unstructured":"Chen Y, Xie Y, Ci H, et al. Plasma metabolites and risk of seven cancers: a two-sample Mendelian randomization study among European descendants. BMC Med. 2024;22(1):90.","journal-title":"BMC Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1443330","DOI":"10.3389\/fendo.2024.1443330","article-title":"Causal links of human serum metabolites on the risk of prostate cancer: insights from genome-wide Mendelian randomization, single-cell RNA sequencing, and metabolic pathway analysis","volume":"15","author":"Pan R","year":"2024","unstructured":"Pan R, Liu J, Xiao M, et al. Causal links of human serum metabolites on the risk of prostate cancer: insights from genome-wide Mendelian randomization, single-cell RNA sequencing, and metabolic pathway analysis. Front Endocrinol (Lausanne). 2024;15:1443330.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12672-025-02388-4","article-title":"Mendelian randomization analysis reveals potential causal relationships between serum lipid metabolites and prostate cancer risk","volume":"16","author":"Guo C","year":"2025","unstructured":"Guo C, Wu L, Xu L. Mendelian randomization analysis reveals potential causal relationships between serum lipid metabolites and prostate cancer risk. Discov Oncol. 2025;16(1):602.","journal-title":"Discov Oncol"},{"key":"ref30","first-page":"15","article-title":"Causality of genetically determined metabolites on susceptibility to prevalent urological cancers: a two-sample Mendelian randomization study and meta-analysis","author":"Dai X","year":"2024","unstructured":"Dai X, Wang H, Zhong R et al. Causality of genetically determined metabolites on susceptibility to prevalent urological cancers: a two-sample Mendelian randomization study and meta-analysis. Front Genet. 2024;Volume 15\u20132024.","journal-title":"Front Genet"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s12672-025-03204-9","article-title":"Associations between circulating metabolites and pca: a bidirectional two-sample Mendelian randomization study","volume":"16","author":"Lv J","year":"2025","unstructured":"Lv J, Deng Y. Associations between circulating metabolites and pca: a bidirectional two-sample Mendelian randomization study. Discover Oncol. 2025;16(1):1370.","journal-title":"Discover Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"100421","DOI":"10.1016\/j.metop.2025.100421","article-title":"Novel causal associations between plasma metabolites and prostate cancer risk revealed by mendelian randomization","volume":"28","author":"Chen H","year":"2025","unstructured":"Chen H, Zhao H, Meng B, et al. Novel causal associations between plasma metabolites and prostate cancer risk revealed by mendelian randomization. Metabol Open. 2025;28:100421.","journal-title":"Metabol Open"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/mc.23929","article-title":"Causal Relationship Between Blood Metabolites and Prostate Cancer Risk: A Two-Sample Mendelian Randomization Study","volume":"64","author":"Liu S","year":"2025","unstructured":"Liu S, Zhu J, Zhang H, et al. Causal Relationship Between Blood Metabolites and Prostate Cancer Risk: A Two-Sample Mendelian Randomization Study. Mol Carcinog. 2025;64(8):1318\u201331.","journal-title":"Mol Carcinog"},{"key":"ref34","first-page":"11","article-title":"Exploring the causal role of plasma metabolites and metabolite ratios in prostate cancer: a two-sample Mendelian randomization study","author":"Feng C","year":"2025","unstructured":"Feng C, Li H, Zhang C et al. Exploring the causal role of plasma metabolites and metabolite ratios in prostate cancer: a two-sample Mendelian randomization study. Front Mol Biosci. 2025;Volume 11\u20132024.","journal-title":"Front Mol Biosci"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/ijc.29576","article-title":"Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study","volume":"137","author":"Mondul AM","year":"2015","unstructured":"Mondul AM, Moore SC, Weinstein SJ, et al. Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study. Int J Cancer. 2015;137(9):2124\u201332.","journal-title":"Int J Cancer"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/ije\/dyab203","article-title":"Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease","volume":"50","author":"Zheng J","year":"2022","unstructured":"Zheng J, Zhang Y, Rasheed H, et al. Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease. Int J Epidemiol. 2022;50(6):1995\u20132010.","journal-title":"Int J Epidemiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1157416","DOI":"10.3389\/fendo.2023.1157416","article-title":"Metabolic drivers of dysglycemia in pregnancy: ethnic-specific GWAS of 146 metabolites and 1-sample Mendelian randomization analyses in a UK multi-ethnic birth cohort","volume":"14","author":"Fuller H","year":"2023","unstructured":"Fuller H, Iles MM, Moore JB, et al. Metabolic drivers of dysglycemia in pregnancy: ethnic-specific GWAS of 146 metabolites and 1-sample Mendelian randomization analyses in a UK multi-ethnic birth cohort. Front Endocrinol (Lausanne). 2023;14:1157416.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1186\/s12967-023-04580-y","article-title":"Causal relationships of circulating amino acids with cardiovascular disease: a trans-ancestry Mendelian randomization analysis","volume":"21","author":"Hu S","year":"2023","unstructured":"Hu S, Lin Z, Hu MJ, et al. Causal relationships of circulating amino acids with cardiovascular disease: a trans-ancestry Mendelian randomization analysis. J Transl Med. 2023;21(1):699.","journal-title":"J Transl Med"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"e1004212","DOI":"10.1371\/journal.pgen.1004212","article-title":"Genetic determinants influencing human serum metabolome among African Americans","volume":"10","author":"Yu B","year":"2014","unstructured":"Yu B, Zheng Y, Alexander D, et al. Genetic determinants influencing human serum metabolome among African Americans. PLoS Genet. 2014;10(3):e1004212.","journal-title":"PLoS Genet"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ajhg.2020.09.003","article-title":"A Genome-wide Association Study Discovers 46 Loci of the Human Metabolome in the Hispanic Community Health Study\/Study of Latinos","volume":"107","author":"Feofanova EV","year":"2020","unstructured":"Feofanova EV, Chen H, Dai Y, et al. A Genome-wide Association Study Discovers 46 Loci of the Human Metabolome in the Hispanic Community Health Study\/Study of Latinos. Am J Hum Genet. 2020;107(5):849\u201363.","journal-title":"Am J Hum Genet"},{"issue":"23","key":"ref41","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.jacc.2021.04.035","article-title":"The ARIC (Atherosclerosis Risk In Communities) Study: JACC Focus Seminar 3\/8","volume":"77","author":"Wright JD","year":"2021","unstructured":"Wright JD, Folsom AR, Coresh J, et al. The ARIC (Atherosclerosis Risk In Communities) Study: JACC Focus Seminar 3\/8. J Am Coll Cardiol. 2021;77(23):2939\u201359.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.annepidem.2010.03.015","article-title":"Design and Implementation of the Hispanic Community Health Study\/Study of Latinos","volume":"20","author":"Sorlie PD","year":"2010","unstructured":"Sorlie PD, Avil\u00e9s-Santa LM, Wassertheil-Smoller S, et al. Design and Implementation of the Hispanic Community Health Study\/Study of Latinos. Ann Epidemiol. 2010;20(8):629\u201341.","journal-title":"Ann Epidemiol"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/aje\/kwt004","article-title":"Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC Study","volume":"178","author":"Zheng Y","year":"2013","unstructured":"Zheng Y, Yu B, Alexander D, et al. Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC Study. Am J Epidemiol. 2013;178(4):534\u201342.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00125-018-4573-7","article-title":"Serum metabolomic profile of incident diabetes","volume":"61","author":"Rebholz CM","year":"2018","unstructured":"Rebholz CM, Yu B, Zheng Z, et al. Serum metabolomic profile of incident diabetes. Diabetologia. 2018;61(5):1046\u201354.","journal-title":"Diabetologia"},{"issue":"7845","key":"ref45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","article-title":"Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program","volume":"590","author":"Taliun D","year":"2021","unstructured":"Taliun D, Harris DN, Kessler MD, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021;590(7845):290\u20139.","journal-title":"Nature"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ajhg.2014.11.005","article-title":"Genetic Association Analysis under Complex Survey Sampling: The Hispanic Community Health Study\/Study of Latinos","volume":"95","author":"Lin D-Y","year":"2014","unstructured":"Lin D-Y, Tao R, Kalsbeek WD, et al. Genetic Association Analysis under Complex Survey Sampling: The Hispanic Community Health Study\/Study of Latinos. Am J Hum Genet. 2014;95(6):675\u201388.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"ref47","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/s41588-023-01534-4","article-title":"Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants","volume":"55","author":"Wang A","year":"2023","unstructured":"Wang A, Shen J, Rodriguez AA, et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat Genet. 2023;55(12):2065\u201374.","journal-title":"Nat Genet"},{"issue":"Database issue","key":"ref48","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gkj144","article-title":"The UCSC Genome Browser Database: update 2006","volume":"34","author":"Hinrichs AS","year":"2006","unstructured":"Hinrichs AS, Karolchik D, Baertsch R, et al. The UCSC Genome Browser Database: update 2006. Nucleic Acids Res. 2006;34(Database issue):D590\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ajhg.2022.04.006","article-title":"TOP-LD: A tool to explore linkage disequilibrium with TOPMed whole-genome sequence data","volume":"109","author":"Huang L","year":"2022","unstructured":"Huang L, Rosen JD, Sun Q, et al. TOP-LD: A tool to explore linkage disequilibrium with TOPMed whole-genome sequence data. Am J Hum Genet. 2022;109(6):1175\u201381.","journal-title":"Am J Hum Genet"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani G","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7:e34408.","journal-title":"eLife"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck M","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040501","article-title":"Mendelian Randomization: Concepts and Scope","volume":"12","author":"Richmond RC","year":"2022","unstructured":"Richmond RC, Davey Smith G. Mendelian Randomization: Concepts and Scope. Cold Spring Harb Perspect Med. 2022;12(1).","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson E","year":"2022","unstructured":"Sanderson E, Glymour MM, Holmes MV, et al. Mendelian randomization. Nat Reviews Methods Primers. 2022;2(1):6.","journal-title":"Nat Reviews Methods Primers"},{"issue":"11","key":"ref54","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/acr.25400","article-title":"A Guide to Understanding Mendelian Randomization Studies","volume":"76","author":"Nguyen K","year":"2024","unstructured":"Nguyen K, Mitchell BD. A Guide to Understanding Mendelian Randomization Studies. Arthritis Care Res (Hoboken). 2024;76(11):1451\u201360.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"ref55","first-page":"40","article-title":"meta: An R package for meta-analysis","volume":"7","author":"Schwarzer G","year":"2007","unstructured":"Schwarzer G. meta: An R package for meta-analysis. R News. 2007;7(3):40\u20135.","journal-title":"R News"},{"issue":"16","key":"ref56","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement","volume":"326","author":"Skrivankova VW","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 2021;326(16):1614\u201321.","journal-title":"JAMA"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"e33624","DOI":"10.1371\/journal.pone.0033624","article-title":"Bagging Statistical Network Inference from Large-Scale Gene Expression Data","volume":"7","author":"Matos Simoes R","year":"2012","unstructured":"de Matos Simoes R, Emmert-Streib F. Bagging Statistical Network Inference from Large-Scale Gene Expression Data. PLoS ONE. 2012;7(3):e33624.","journal-title":"PLoS ONE"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei C","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383.","journal-title":"PLoS Genet"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"e1008720","DOI":"10.1371\/journal.pgen.1008720","article-title":"Eliciting priors and relaxing the single causal variant assumption in colocalisation analyses","volume":"16","author":"Wallace C","year":"2020","unstructured":"Wallace C. Eliciting priors and relaxing the single causal variant assumption in colocalisation analyses. PLoS Genet. 2020;16(4):e1008720.","journal-title":"PLoS Genet"},{"issue":"16","key":"ref60","doi-asserted-by":"crossref","first-page":"e034749","DOI":"10.1161\/JAHA.124.034749","article-title":"Systematic Druggable Genome-Wide Mendelian Randomization Identifies Therapeutic Targets for Functional Outcome After Ischemic Stroke","volume":"13","author":"Zhang LY","year":"2024","unstructured":"Zhang LY, Chu YH, You YF, et al. Systematic Druggable Genome-Wide Mendelian Randomization Identifies Therapeutic Targets for Functional Outcome After Ischemic Stroke. J Am Heart Assoc. 2024;13(16):e034749.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12933-022-01613-6","article-title":"Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis","volume":"21","author":"Wang K","year":"2022","unstructured":"Wang K, Shi M, Huang C, et al. Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis. Cardiovasc Diabetol. 2022;21(1):192.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13148-025-01850-y","article-title":"Mendelian randomization provides a multi-omics perspective on the regulation of genes involved in ribosome biogenesis in relation to cardiac structure and function","volume":"17","author":"Wei S","year":"2025","unstructured":"Wei S, Shen R, Lu X, et al. Mendelian randomization provides a multi-omics perspective on the regulation of genes involved in ribosome biogenesis in relation to cardiac structure and function. Clin Epigenetics. 2025;17(1):42.","journal-title":"Clin Epigenetics"},{"issue":"5","key":"ref63","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","article-title":"Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches","volume":"109","author":"Zuber V","year":"2022","unstructured":"Zuber V, Grinberg NF, Gill D, et al. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches. Am J Hum Genet. 2022;109(5):767\u201382.","journal-title":"Am J Hum Genet"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"905178","DOI":"10.3389\/fpubh.2022.905178","article-title":"Systematic evaluation for the causal effects of blood metabolites on osteoporosis: Genetic risk score and Mendelian randomization","volume":"10","author":"Yu XH","year":"2022","unstructured":"Yu XH, Cao RR, Yang YQ, et al. Systematic evaluation for the causal effects of blood metabolites on osteoporosis: Genetic risk score and Mendelian randomization. Front Public Health. 2022;10:905178.","journal-title":"Front Public Health"},{"issue":"12","key":"ref65","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1002\/cam4.6022","article-title":"Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: A Mendelian randomization study","volume":"12","author":"Yun Z","year":"2023","unstructured":"Yun Z, Guo Z, Li X, et al. Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: A Mendelian randomization study. Cancer Med. 2023;12(12):13784\u201399.","journal-title":"Cancer Med"},{"issue":"4","key":"ref66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/aje\/kwu283","article-title":"Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects","volume":"181","author":"Burgess S","year":"2015","unstructured":"Burgess S, Thompson SG. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181(4):251\u201360.","journal-title":"Am J Epidemiol"},{"issue":"25","key":"ref67","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1002\/sim.9133","article-title":"Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization","volume":"40","author":"Sanderson E","year":"2021","unstructured":"Sanderson E, Spiller W, Bowden J. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization. Stat Med. 2021;40(25):5434\u201352.","journal-title":"Stat Med"},{"issue":"9","key":"ref68","doi-asserted-by":"crossref","first-page":"e1003786","DOI":"10.1371\/journal.pmed.1003786","article-title":"The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium","volume":"18","author":"Guida F","year":"2021","unstructured":"Guida F, Tan VY, Corbin LJ, et al. The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium. PLoS Med. 2021;18(9):e1003786.","journal-title":"PLoS Med"},{"issue":"16","key":"ref69","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1158\/0008-5472.CAN-20-0985","article-title":"LDtrait: An Online Tool for Identifying Published Phenotype Associations in Linkage Disequilibrium","volume":"80","author":"Lin SH","year":"2020","unstructured":"Lin SH, Brown DW, Machiela MJ. LDtrait: An Online Tool for Identifying Published Phenotype Associations in Linkage Disequilibrium. Cancer Res. 2020;80(16):3443\u20136.","journal-title":"Cancer Res"},{"issue":"7571","key":"ref70","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton A","year":"2015","unstructured":"The 1000 Genomes Project Consortium, Auton A, Brooks LD, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68\u201374.","journal-title":"Nature"},{"issue":"12","key":"ref71","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/s41588-023-01534-4","article-title":"Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants","volume":"55","author":"Wang A","year":"2023","unstructured":"Wang A, Shen J, Rodriguez AA, et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat Genet. 2023;55(12):2065\u201374.","journal-title":"Nat Genet"},{"issue":"7","key":"ref72","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jmedgenet-2012-100918","article-title":"wANNOVAR: annotating genetic variants for personal genomes via the web","volume":"49","author":"Chang X","year":"2012","unstructured":"Chang X, Wang K. wANNOVAR: annotating genetic variants for personal genomes via the web. J Med Genet. 2012;49(7):433\u20136.","journal-title":"J Med Genet"},{"issue":"D1","key":"ref73","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart DS","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"ref74","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5522","article-title":"New insights into lipid metabolism and prostate cancer (Review)","volume":"62","author":"Zhang Z","year":"2023","unstructured":"Zhang Z, Wang W, Kong P et al. New insights into lipid metabolism and prostate cancer (Review). Int J Oncol. 2023;62(6).","journal-title":"Int J Oncol"},{"issue":"5","key":"ref75","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/advances\/nmaa055","article-title":"Consumption of Fish and \u03c9-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies","volume":"11","author":"Lee KH","year":"2020","unstructured":"Lee KH, Seong HJ, Kim G, et al. Consumption of Fish and \u03c9-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies. Adv Nutr. 2020;11(5):1134\u201349.","journal-title":"Adv Nutr"},{"issue":"8","key":"ref76","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41416-020-0761-6","article-title":"Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials","volume":"122","author":"Hanson S","year":"2020","unstructured":"Hanson S, Thorpe G, Winstanley L, et al. Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials. Br J Cancer. 2020;122(8):1260\u201370.","journal-title":"Br J Cancer"},{"issue":"9","key":"ref77","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju240","article-title":"Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies","volume":"106","author":"Crowe FL","year":"2014","unstructured":"Crowe FL, Appleby PN, Travis RC et al. Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies. J Natl Cancer Inst. 2014;106(9).","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"ref78","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/ijc.35226","article-title":"Associations of plasma omega-6 and omega-3 fatty acids with overall and 19 site-specific cancers: A population-based cohort study in UK Biobank","volume":"156","author":"Zhang Y","year":"2025","unstructured":"Zhang Y, Sun Y, Song S, et al. Associations of plasma omega-6 and omega-3 fatty acids with overall and 19 site-specific cancers: A population-based cohort study in UK Biobank. Int J Cancer. 2025;156(6):1154\u201372.","journal-title":"Int J Cancer"},{"issue":"1","key":"ref79","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1038\/s41467-023-39865-9","article-title":"Circulating trans fatty acids are associated with prostate cancer in Ghanaian and American men","volume":"14","author":"Minas TZ","year":"2023","unstructured":"Minas TZ, Lord BD, Zhang AL, et al. Circulating trans fatty acids are associated with prostate cancer in Ghanaian and American men. Nat Commun. 2023;14(1):4322.","journal-title":"Nat Commun"},{"issue":"5","key":"ref80","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ajhg.2012.03.014","article-title":"Genetic adaptation of fatty-acid metabolism: a human-specific haplotype increasing the biosynthesis of long-chain omega-3 and omega-6 fatty acids","volume":"90","author":"Ameur A","year":"2012","unstructured":"Ameur A, Enroth S, Johansson A, et al. Genetic adaptation of fatty-acid metabolism: a human-specific haplotype increasing the biosynthesis of long-chain omega-3 and omega-6 fatty acids. Am J Hum Genet. 2012;90(5):809\u201320.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"ref81","doi-asserted-by":"crossref","first-page":"e44926","DOI":"10.1371\/journal.pone.0044926","article-title":"Adaptive evolution of the FADS gene cluster within Africa","volume":"7","author":"Mathias RA","year":"2012","unstructured":"Mathias RA, Fu W, Akey JM, et al. Adaptive evolution of the FADS gene cluster within Africa. PLoS ONE. 2012;7(9):e44926.","journal-title":"PLoS ONE"},{"issue":"3","key":"ref82","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/ije\/dyy202","article-title":"Contextualizing selection bias in Mendelian randomization: how bad is it likely to be?","volume":"48","author":"Gkatzionis A","year":"2019","unstructured":"Gkatzionis A, Burgess S. Contextualizing selection bias in Mendelian randomization: how bad is it likely to be? Int J Epidemiol. 2019;48(3):691\u2013701.","journal-title":"Int J Epidemiol"},{"issue":"9","key":"ref83","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju240","article-title":"Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies","volume":"106","author":"Crowe FL","year":"2014","unstructured":"Crowe FL, Appleby PN, Travis RC et al. Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies. J Natl Cancer Inst. 2014;106(9).","journal-title":"J Natl Cancer Inst"},{"key":"ref84","author":"Downie CG","year":"2024","unstructured":"Downie CG, Highland HM, Alotaibi M et al. Genome-wide association study reveals shared and distinct genetic architecture underlying fatty acid and bioactive oxylipin metabolites in the Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL). medRxiv. 2024."},{"issue":"3","key":"ref85","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/path.2456","article-title":"SmgGDS is up-regulated in prostate carcinoma and promotes tumour phenotypes in prostate cancer cells","volume":"217","author":"Zhi H","year":"2009","unstructured":"Zhi H, Yang X, Kuhnmuench J, et al. SmgGDS is up-regulated in prostate carcinoma and promotes tumour phenotypes in prostate cancer cells. J Pathol. 2009;217(3):389\u201397.","journal-title":"J Pathol"},{"issue":"5","key":"ref86","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in Mendelian randomization studies","volume":"42","author":"Brion M-JA","year":"2012","unstructured":"Brion M-JA, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2012;42(5):1497\u2013501.","journal-title":"Int J Epidemiol"},{"issue":"9","key":"ref87","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/bjc.2016.305","article-title":"Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"115","author":"Huang J","year":"2016","unstructured":"Huang J, Mondul AM, Weinstein SJ, et al. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Br J Cancer. 2016;115(9):1087\u201395.","journal-title":"Br J Cancer"},{"issue":"8","key":"ref88","doi-asserted-by":"crossref","first-page":"e1600800","DOI":"10.1126\/sciadv.1600800","article-title":"Loss-of-function variants influence the human serum metabolome","volume":"2","author":"Yu B","year":"2016","unstructured":"Yu B, Li AH, Metcalf GA, et al. Loss-of-function variants influence the human serum metabolome. Sci Adv. 2016;2(8):e1600800.","journal-title":"Sci Adv"},{"issue":"44","key":"ref89","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1038\/s41388-021-02008-9","article-title":"Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel","volume":"40","author":"Labanca E","year":"2021","unstructured":"Labanca E, Bizzotto J, Sanchis P, et al. Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel. Oncogene. 2021;40(44):6284\u201398.","journal-title":"Oncogene"},{"issue":"6","key":"ref90","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1593\/tlo.13619","article-title":"Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes","volume":"6","author":"Shen J","year":"2013","unstructured":"Shen J, Yan L, Liu S, et al. Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes. Transl Oncol. 2013;6(6):757\u201365.","journal-title":"Transl Oncol"},{"issue":"10","key":"ref91","doi-asserted-by":"crossref","first-page":"e74386","DOI":"10.1371\/journal.pone.0074386","article-title":"A-methylacyl-CoA racemase (AMACR) and prostate-cancer risk: a meta-analysis of 4,385 participants","volume":"8","author":"Jiang N","year":"2013","unstructured":"Jiang N, Zhu S, Chen J, et al. A-methylacyl-CoA racemase (AMACR) and prostate-cancer risk: a meta-analysis of 4,385 participants. PLoS ONE. 2013;8(10):e74386.","journal-title":"PLoS ONE"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fmolb.2020.00153","article-title":"Current Knowledge on the Function of \u03b1-Methyl Acyl-CoA Racemase in Human Diseases","volume":"7","author":"Kong G","year":"2020","unstructured":"Kong G, Lee H, Tran Q, et al. Current Knowledge on the Function of \u03b1-Methyl Acyl-CoA Racemase in Human Diseases. Front Mol Biosci. 2020;7:153.","journal-title":"Front Mol Biosci"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2017.05.017","article-title":"MACF1, versatility in tissue-specific function and in human disease","volume":"69","author":"Hu L","year":"2017","unstructured":"Hu L, Xiao Y, Xiong Z, et al. MACF1, versatility in tissue-specific function and in human disease. Semin Cell Dev Biol. 2017;69:3\u20138.","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"ref94","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbalip.2009.12.004","article-title":"Fatty acid 2-Hydroxylation in mammalian sphingolipid biology","volume":"1801","author":"Hama H","year":"2010","unstructured":"Hama H. Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. Biochim Biophys Acta. 2010;1801(4):405\u201314.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"ref95","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14728222.2023.2259099","article-title":"Fatty acid-mediated signaling as a target for developing type 1 diabetes therapies","volume":"27","author":"D\u00edaz Ludovico I","year":"2023","unstructured":"D\u00edaz Ludovico I, Sarkar S, Elliott E, et al. Fatty acid-mediated signaling as a target for developing type 1 diabetes therapies. Expert Opin Ther Targets. 2023;27(9):793\u2013806.","journal-title":"Expert Opin Ther Targets"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"101068","DOI":"10.1016\/j.plipres.2020.101068","article-title":"Emerging roles of lysophospholipids in health and disease","volume":"80","author":"Tan ST","year":"2020","unstructured":"Tan ST, Ramesh T, Toh XR, et al. Emerging roles of lysophospholipids in health and disease. Prog Lipid Res. 2020;80:101068.","journal-title":"Prog Lipid Res"},{"issue":"49","key":"ref97","doi-asserted-by":"crossref","first-page":"84902","DOI":"10.18632\/oncotarget.17926","article-title":"Increased transcriptional and metabolic capacity for lipid metabolism in the peripheral zone of the prostate may underpin its increased susceptibility to cancer","volume":"8","author":"Al Kadhi O","year":"2017","unstructured":"Al Kadhi O, Traka MH, Melchini A, et al. Increased transcriptional and metabolic capacity for lipid metabolism in the peripheral zone of the prostate may underpin its increased susceptibility to cancer. Oncotarget. 2017;8(49):84902\u201316.","journal-title":"Oncotarget"},{"issue":"5","key":"ref98","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.semcdb.2004.05.001","article-title":"Mechanisms of lysophosphatidic acid production","volume":"15","author":"Aoki J","year":"2004","unstructured":"Aoki J. Mechanisms of lysophosphatidic acid production. Semin Cell Dev Biol. 2004;15(5):477\u201389.","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"ref99","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/pros.20879","article-title":"Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: Relevance to prostate cancer and benign hyperplasia","volume":"69","author":"Zeng Y","year":"2009","unstructured":"Zeng Y, Kakehi Y, Nouh MAAM, et al. Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: Relevance to prostate cancer and benign hyperplasia. Prostate. 2009;69(3):283\u201392.","journal-title":"Prostate"},{"issue":"4","key":"ref100","article-title":"Re-Discovery of Pyrimidine Salvage as Target in Cancer Therapy","volume":"11","author":"Walter M","year":"2022","unstructured":"Walter M, Herr P. Re-Discovery of Pyrimidine Salvage as Target in Cancer Therapy. Cells [Internet]. 2022; 11(4).","journal-title":"Cells [Internet]"},{"issue":"5","key":"ref101","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s11306-014-0643-0","article-title":"1-stearoylglycerol is associated with risk of prostate cancer: results from serum metabolomic profiling","volume":"10","author":"Mondul AM","year":"2014","unstructured":"Mondul AM, Moore SC, Weinstein SJ, et al. 1-stearoylglycerol is associated with risk of prostate cancer: results from serum metabolomic profiling. Metabolomics. 2014;10(5):1036\u201341.","journal-title":"Metabolomics"},{"issue":"12","key":"ref102","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1002\/ijc.32218","article-title":"Prospective serum metabolomic profiling of lethal prostate cancer","volume":"145","author":"Huang J","year":"2019","unstructured":"Huang J, Mondul AM, Weinstein SJ, et al. Prospective serum metabolomic profiling of lethal prostate cancer. Int J Cancer. 2019;145(12):3231\u201343.","journal-title":"Int J Cancer"},{"issue":"1","key":"ref103","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.euo.2019.07.005","article-title":"Plasma Metabolomic Profiles and Risk of Advanced and Fatal Prostate Cancer","volume":"4","author":"Wang Y","year":"2021","unstructured":"Wang Y, Jacobs EJ, Carter BD, et al. Plasma Metabolomic Profiles and Risk of Advanced and Fatal Prostate Cancer. Eur Urol Oncol. 2021;4(1):56\u201365.","journal-title":"Eur Urol Oncol"},{"key":"ref104","author":"Rocha I","unstructured":"Rocha I, de Brito IR, Carvalho HF et al. Modified Nucleosides as Potential Biomarkers of Prostate Cancer: Targeted Metabolomics of In Vitro Cell Samples by MEKC-UV. ELECTROPHORESIS.n\/a(n\/a)."},{"issue":"1","key":"ref105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40170-016-0161-9","article-title":"The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study","volume":"4","author":"Kelly RS","year":"2016","unstructured":"Kelly RS, Sinnott JA, Rider JR, et al. The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study. Cancer Metabolism. 2016;4(1):22.","journal-title":"Cancer Metabolism"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"1418283","DOI":"10.3389\/fonc.2024.1418283","article-title":"Elucidating the causal relationship between 486 genetically predicted blood metabolites and the risk of gastric cancer: a comprehensive Mendelian randomization analysis","volume":"14","author":"Qian L","year":"2024","unstructured":"Qian L, Song J, Zhang X, et al. Elucidating the causal relationship between 486 genetically predicted blood metabolites and the risk of gastric cancer: a comprehensive Mendelian randomization analysis. Front Oncol. 2024;14:1418283.","journal-title":"Front Oncol"},{"issue":"1","key":"ref107","article-title":"Erythritol: An In-Depth Discussion of Its Potential to Be a Beneficial Dietary Component","volume":"15","author":"Mazi TA","year":"2023","unstructured":"Mazi TA, Stanhope KL. Erythritol: An In-Depth Discussion of Its Potential to Be a Beneficial Dietary Component. Nutrients. 2023;15(1).","journal-title":"Nutrients"},{"key":"ref108","first-page":"11","article-title":"The Role of the Pentose Phosphate Pathway in Diabetes and Cancer","author":"Ge T","year":"2020","unstructured":"Ge T, Yang J, Zhou S et al. The Role of the Pentose Phosphate Pathway in Diabetes and Cancer. Front Endocrinol. 2020;Volume 11\u20132020.","journal-title":"Front Endocrinol"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jpba.2014.12.026","article-title":"Urine metabolic fingerprinting using LC\u2013MS and GC\u2013MS reveals metabolite changes in prostate cancer: A pilot study","volume":"111","author":"Struck-Lewicka W","year":"2015","unstructured":"Struck-Lewicka W, Kordalewska M, Bujak R, et al. Urine metabolic fingerprinting using LC\u2013MS and GC\u2013MS reveals metabolite changes in prostate cancer: A pilot study. J Pharm Biomed Anal. 2015;111:351\u201361.","journal-title":"J Pharm Biomed Anal"},{"issue":"17","key":"ref110","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15174356","article-title":"Metabolic Reprogramming by Ribitol Expands the Therapeutic Window of BETi JQ1 against Breast Cancer","volume":"15","author":"Doddapaneni R","year":"2023","unstructured":"Doddapaneni R, Tucker JD, Lu PJ et al. Metabolic Reprogramming by Ribitol Expands the Therapeutic Window of BETi JQ1 against Breast Cancer. Cancers (Basel). 2023;15(17).","journal-title":"Cancers (Basel)"},{"issue":"5","key":"ref111","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4103\/aja2021104","article-title":"Mannose inhibits the growth of prostate cancer through a mitochondrial mechanism","volume":"24","author":"Deng YL","year":"2022","unstructured":"Deng YL, Liu R, Cai ZD, et al. Mannose inhibits the growth of prostate cancer through a mitochondrial mechanism. Asian J Androl. 2022;24(5):540\u20138.","journal-title":"Asian J Androl"},{"issue":"3","key":"ref112","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11306-018-1332-1","article-title":"A comparison of human serum and plasma metabolites using untargeted (1)H NMR spectroscopy and UPLC-MS","volume":"14","author":"Kaluarachchi M","year":"2018","unstructured":"Kaluarachchi M, Boulang\u00e9 CL, Karaman I, et al. A comparison of human serum and plasma metabolites using untargeted (1)H NMR spectroscopy and UPLC-MS. Metabolomics. 2018;14(3):32.","journal-title":"Metabolomics"},{"key":"ref113","volume-title":"Appendix1_STROBE-MR-checklist.txt","author":"Additonal File 1","unstructured":"Additonal File 1. Appendix1_STROBE-MR-checklist.txt. STROBE MR Checklist."},{"key":"ref114","author":"Tables S","unstructured":"Tables S. MR_supplement_tables_submitted.xlxs. Supplementary information and supplementary results."},{"key":"ref115","author":"Supplementary","unstructured":"Supplementary, Figures. MR_supplement_submitted.txt Supplementary figures and additional acknowledgments."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9708129\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9708129\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T07:10:20Z","timestamp":1780211420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9708129\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":115,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9708129\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,5,31]]},"subtype":"preprint"}}